Piper Sandler raises Myriad Genetics to neutral from underweight, target to $5 from $2
MYGN•Piper Sandler raised its rating on Myriad Genetics to neutral from underweight and its target price to $5 from $2.
MYGN•MYGN•MYGN•Piper Sandler raised its rating on Myriad Genetics to neutral from underweight and its target price to $5 from $2.
